Attention: Mr W Bertrand General CounselPersonal and Confidential • May 3rd, 2007 • AstraZeneca Biopharmaceuticals Inc. • Biological products, (no disgnostic substances)
It has been agreed that it may be appropriate to facilitate transition for AstraZeneca PLC (the Company) and its affiliates to disclose to you confidential data concerning the Company and its affiliates.
FACILITY AGREEMENT dated 1 May 2007 for ASTRAZENECA PLC as Borrower arranged by CITIGROUP GLOBAL MARKETS LIMITED DEUTSCHE BANK AG, LONDON BRANCH and HSBC BANK PLC with HSBC BANK PLC acting as Agent $15,000,000,000 FACILITY AGREEMENTFacility Agreement • May 3rd, 2007 • AstraZeneca Biopharmaceuticals Inc. • Biological products, (no disgnostic substances)
